Original Research
Accepted on 30 Nov 2024
Mitigating Inflammation and Fibrosis: The Therapeutic Potential of Quercetin Liposomes in COPD
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503283
Type at least 3 characters
581 articles
Articles
Case Report
Published on 22 Nov 2024
Rare cancer with primary pleural epithelioid hemangioendothelioma diagnosed by thoracoscopic biopsy achieving disease control after 16 months: case report and literature review
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1482154
- 130 views
Review
Published on 13 Nov 2024
Pyroptosis in asthma: inflammatory phenotypes, immune and non-immune cells, and novel treatment approaches
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1452845
- 230 views
Original Research
Accepted on 11 Nov 2024
α-Bisabolol alleviates diesel exhaust particles-induced lung injury and mitochondrial dysfunction by regulating inflammatory, oxidative stress and apoptotic biomarkers through the c-Jun N-terminal kinase signalling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1485101
Review
Published on 08 Nov 2024
Bacteria and fungi of the lung: allies or enemies?
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1497173
- 250 views
Case Report
Published on 07 Nov 2024
Characteristics of voriconazole-induced visual disturbances and hallucinations: case reports and literature review
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1420046
- 242 views
Original Research
Published on 28 Oct 2024
Therapeutic targets for lung cancer: genome-wide Mendelian randomization and colocalization analyses
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1441233
- 648 views
Correction
Published on 25 Oct 2024
Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1497520
- 208 views
Review
Published on 09 Oct 2024
Emerging small-molecule antiviral agents in long COVID prevention
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1457672
- 1,051 views
Review
Published on 08 Oct 2024
Current landscape of cystic fibrosis gene therapy
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476331
- 1,637 views
Original Research
Published on 25 Sep 2024
Airspaces-derived exosomes contain disease-relevant protein signatures in a mouse model of cystic fibrosis (CF)-like mucoinflammatory lung disease
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1460692
- 773 views
Review
Published on 24 Sep 2024
The critical roles of caveolin-1 in lung diseases
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1417834
- 949 views
Review
Published on 23 Sep 2024
3D cell culture models in research: applications to lung cancer pharmacology
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1438067
- 1,551 views
Original Research
Published on 19 Sep 2024
The glucocorticoid dose-mortality nexus in pneumonia patients: unveiling the threshold effect
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445979
- 399 views
Original Research
Published on 13 Sep 2024
Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1402386
- 1,319 views
Original Research
Published on 11 Sep 2024
Triiodothyronine acts on DAO to regulate pulmonary fibrosis progression by facilitating cell senescence through the p53/p21 signaling pathway
in Respiratory Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1433186
- 780 views